Clinical trials recruiting in Dendermonde, Belgium

Phase breakdown

Conditions recruiting in Dendermonde, Belgium

Recruiting trials in Dendermonde, Belgium

• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
  NCT05298722 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Prospective Prostate Cancer and Patient-reported Outcomes Registry
  NCT04694924 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Dendermonde, Belgium?

4 recruiting trials have at least one study site in Dendermonde, Belgium.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.